SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-21-010889
Filing Date
2021-05-10
Accepted
2021-05-10 16:52:52
Documents
15

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 1770351
2 formdrsa_001.jpg GRAPHIC 11011
3 formdrsa_002.jpg GRAPHIC 127330
4 formdrsa_017.jpg GRAPHIC 315756
5 formdrsa_004.jpg GRAPHIC 35700
6 formdrsa_005.jpg GRAPHIC 44907
7 formdrsa_006.jpg GRAPHIC 32333
8 formdrsa_007.jpg GRAPHIC 53426
9 formdrsa_008.jpg GRAPHIC 162055
10 formdrsa_009.jpg GRAPHIC 127330
11 formdrsa_011.jpg GRAPHIC 37387
12 formdrsa_012.jpg GRAPHIC 44959
13 formdrsa_013.jpg GRAPHIC 32420
14 formdrsa_014.jpg GRAPHIC 13551
15 formdrsa_015.jpg GRAPHIC 162055
  Complete submission text file 0001493152-21-010889.txt   3425697
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-254979 | Film No.: 21908062
SIC: 2834 Pharmaceutical Preparations